The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Infectious COVID-19 virus can be found in a COVID-19 patient at the end of its incubation period and after symptoms onset. The most critical work at present for COVID-19 prevention and control is to facilitate early detection, early reporting, early quarantine, and early treatment of the disease, which can help save lives.
Wondfo has taken swift actions in the wake of COVID-19 and has successfully developed three kinds of COVID-19 test kits - RT-PCR test, antigen test, and antibody test - that make contributions to the global battle against the virus.
Diagnosis & Differentiation
Wondfo has been successfully developed kinds of diagnostic products to efficiently detect COVID-19 virus since January 2020. These products are developed based on three professional methods – Nucleic Acid (RT-PCR), Antigen, Antibody.